Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd

<< Previous

Bullboard Posts

Next >>

Post by whitenorth72on Jun 06, 2024 11:14am

161 Views

Post# 36075315

This is new updated investor pitch.

This video shows a direct path to positive cash flow.
The partnerships are incredible.
Highlights.
60 year barium mine with new zones to be discovered.
Rain cage carbon farm incorporated into plant design.
Multiple contracts pending.
Gadolinium
Bismuth

https://m.youtube.com/watch?v=q1n774rK0ug

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3